Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease

Por Julio M. Martinez-Moreno, Miguel Fontecha-Barriuso, Diego Martin-Sanchez, Juan Guerrero-Mauvecin, Elena Goma-Garces, Beatriz Fernandez-Fernandez, Sol Carriazo, Maria D. Sanchez-Niño, Adrian M. Ramos, Marta Ruiz-Ortega, Alberto Ortiz, Ana B. Sanz
Publicado em 2020-06-01